Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with α-tocopheryl nicotinate
- 31 October 1990
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 84 (2-3), 213-217
- https://doi.org/10.1016/0021-9150(90)90093-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Lack of effect of probucol on serum lipoprotein(a) levelsAtherosclerosis, 1989
- Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acidJournal of Internal Medicine, 1989
- Enzyme-linked immunosorbent assay of lipoprotein(a) in serum and cord bloodClinica Chimica Acta; International Journal of Clinical Chemistry, 1988
- Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitorJournal of Molecular Medicine, 1988
- Teaching old dogmas new tricksNature, 1987
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Levels of lipoprotein Lp(a) decline with neomycin and niacin treatmentAtherosclerosis, 1985
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a): A dose-response study of the effects of cholestyramine in hypercholesterolaemiaAtherosclerosis, 1982
- Lp(a) lipoprotein: Relationship to sinking pre-β lipoprotein, hyperlipoproteinemia, and apolipoprotein BMetabolism, 1975